2014
DOI: 10.1097/prs.0000000000000226
|View full text |Cite
|
Sign up to set email alerts
|

Nerve Conduits for Peripheral Nerve Surgery

Abstract: Autologous nerve grafts are the current criterion standard for repair of peripheral nerve injuries when the transected nerve ends are not amenable to primary end-to-end tensionless neurorrhaphy. However, donor-site morbidities such as neuroma formation and permanent loss of function have led to tremendous interest in developing an alternative to this technique. Artificial nerve conduits have therefore emerged as an alternative to autologous nerve grafting for the repair of short peripheral nerve defects of les… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
78
1
2

Year Published

2015
2015
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 109 publications
(83 citation statements)
references
References 87 publications
2
78
1
2
Order By: Relevance
“…Recent modifications of this include the use of processed nerve allografts20 and nerve conduits 21. Allografts appear to perform better than nerve conduits, but there are insufficient data to confirm that they are equivalent to nerve autografts, particularly in major mixed motor nerves.…”
Section: Introductionmentioning
confidence: 99%
“…Recent modifications of this include the use of processed nerve allografts20 and nerve conduits 21. Allografts appear to perform better than nerve conduits, but there are insufficient data to confirm that they are equivalent to nerve autografts, particularly in major mixed motor nerves.…”
Section: Introductionmentioning
confidence: 99%
“…Nerve regeneration becomes more evident in SIS if the defects between proximal and distal stumps are less than 10 mm (14,16). Data regarding the effectiveness of SIS are still lacking and there are no comparisons with other conduits (29). …”
Section: Discussionmentioning
confidence: 99%
“…SIS is a commercially available product that was FDA approved in 2003 (29). However, in experimental studies on neural regeneration, the investigators have preferred to prepare SIS grafts in their own facilities (14,15,25).…”
Section: Discussionmentioning
confidence: 99%
“…Later time point (ie, 15 weeks) observations may show experimental and control groups to be equivalent because of the enhanced regenerative capacity of the rodent nervous system, and this could mask any differences seen between groups. 3,6,31,32 At 6 weeks, Wallerian degeneration is complete, yet axonal regeneration is still ongoing, providing the ability to more accurately compare recovery differences between both groups. Therefore, this time point strengthens the validity of improved sensory axons at least early in the nerve recovery process when utilizing the UBM conduit.…”
Section: Discussionmentioning
confidence: 99%
“…35 Current Food and Drug Administration–approved biodegradable conduits in the market have had variable results in comparison with autografts both clinically and experimentally. These variable results have precluded conduit-based repair full acceptance in bridging segmental peripheral nerve loss, 2,3,6,7 leading bioengineers continue to search for conduit material that will consistently outperform autografts.…”
mentioning
confidence: 99%